Why we should not routinely apply irreversible electroporation as an alternative curative treatment modality for localized prostate cancer at this stage
Crossref DOI link: https://doi.org/10.1007/s00345-016-1838-y
Published Online: 2016-05-04
Published Print: 2017-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wendler, J. J.
Ganzer, R.
Hadaschik, B.
Blana, A.
Henkel, T.
Köhrmann, K. U.
Machtens, S.
Roosen, A.
Salomon, G.
Sentker, L.
Witzsch, U.
Schlemmer, H. P.
Baumunk, D.
Köllermann, J.
Schostak, M.
Liehr, U. B.
Text and Data Mining valid from 2016-05-04